风湿免疫科指南

订阅

MedSci主页 / 所有栏目 / 风湿免疫科指南

2018 CRA建议：系统性红斑狼疮的评估和监测

2018-09-01 加拿大风湿病学协会 J Rheumatol. 2018 Sep 1.

系统性红斑狼疮

2018年9月，加拿大风湿病学协会(CRA)发布了系统性红斑狼疮的评估和监测建议，本文针对系统性红斑狼疮的评估和监测共提出15条建议内容，主要涉及诊断，疾病活动性以及损伤评估，建议应用有效的疾病活动评分标准和损伤评分进行评估。

中文标题：

2018 CRA建议：系统性红斑狼疮的评估和监测

英文标题：

Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.

发布机构：

加拿大风湿病学协会

发布日期：

2018-09-01

简要介绍：

2018年9月，加拿大风湿病学协会(CRA)发布了系统性红斑狼疮的评估和监测建议，本文针对系统性红斑狼疮的评估和监测共提出15条建议内容，主要涉及诊断，疾病活动性以及损伤评估，建议应用有效的疾病活动评分标准和损伤评分进行评估。 

拓展指南：与系统性红斑狼疮相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 CRA建议：系统性红斑狼疮的评估和监测)] GetToolGuiderByIdResponse(projectId=1, id=df17a1c0016360af, title=2018 CRA建议：系统性红斑狼疮的评估和监测, enTitle=Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus., guiderFrom=J Rheumatol. 2018 Sep 1., authorId=null, author=, summary=2018年9月，加拿大风湿病学协会(CRA)发布了系统性红斑狼疮的评估和监测建议，本文针对系统性红斑狼疮的评估和监测共提出15条建议内容，主要涉及诊断，疾病活动性以及损伤评估，建议应用有效的疾病活动评分标准和损伤评分进行评估。 , cover=, journalId=null, articlesId=null, associationId=1157, associationName=加拿大风湿病学协会, associationIntro=null, copyright=0, guiderPublishedTime=Sat Sep 01 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年9月，加拿大风湿病学协会(CRA)发布了系统性红斑狼疮的评估和监测建议，本文针对系统性红斑狼疮的评估和监测共提出15条建议内容，主要涉及诊断，疾病活动性以及损伤评估，建议应用有效的疾病活动评分标准和损伤评分进行评估。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>系统性红斑狼疮</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=8c0bf1c001a5907c" title="2017 欧洲循证建议：儿童时期发病的系统性红斑狼疮的诊断和治疗" target=_blank>2017 欧洲循证建议：儿童时期发病的系统性红斑狼疮的诊断和治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=6a9d61c0012a9579" title="2016 EULAR循证建议：系统性红斑狼疮和／或抗磷脂综合征女性患者计划生育，辅助生殖，妊娠和更年期管理及健康" target=_blank>2016 EULAR循证建议：系统性红斑狼疮和／或抗磷脂综合征女性患者计划生育，辅助生殖，妊娠和更年期管理及健康</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=beb1e1c001139aa2" title="中国成人系统性红斑狼疮相关肺动脉高压诊治共识" target=_blank>中国成人系统性红斑狼疮相关肺动脉高压诊治共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=f01b21c00111a226" title="风湿免疫疾病( 系统性红斑狼疮) 超药品说明书用药专家共识" target=_blank>风湿免疫疾病( 系统性红斑狼疮) 超药品说明书用药专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=2a2421c0010e9227" title="2014 糖皮质激素在系统性红斑狼疮患者合理应用的专家共识" target=_blank>2014 糖皮质激素在系统性红斑狼疮患者合理应用的专家共识</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E7%B3%BB%E7%BB%9F%E6%80%A7%E7%BA%A2%E6%96%91%E7%8B%BC%E7%96%AE" target=_blank>有关系统性红斑狼疮更多指南</a></ul>, tagList=[TagDto(tagId=648, tagName=系统性红斑狼疮)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7704, appHits=683, showAppHits=16, pcHits=5198, showPcHits=2476, likes=126, shares=29, comments=32, approvalStatus=1, publishedTime=Wed Sep 05 22:33:56 CST 2018, publishedTimeString=2018-09-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Sep 05 22:33:56 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 20:25:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 CRA建议：系统性红斑狼疮的评估和监测)])
2018 CRA建议：系统性红斑狼疮的评估和监测
下载请点击：
评论区 (32)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=908082, encodeId=610490808290, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Tue Dec 15 08:56:15 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364084, encodeId=d2f836408479, content=?(??????????? ?)?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bt2rsYee98yUOKajPOWnGaibjDJuTpdv0wXJL1NNezybxOqRvAVtLEQQ4aQeMbA4iavvHxw5wMtZUaqrq6ZGQMFg/132, createdBy=37ff2445159, createdName=lxxinhuo, createdTime=Thu Apr 04 00:01:21 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343215, encodeId=e943343215d8, content=嗯嗯，学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Thu Sep 06 06:42:10 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343137, encodeId=a30134313ee6, content=好文章谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 05 23:54:27 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343136, encodeId=328d3431368c, content=好文章谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 05 23:54:22 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2020-12-15 ms4000002082197205

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=908082, encodeId=610490808290, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Tue Dec 15 08:56:15 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364084, encodeId=d2f836408479, content=?(??????????? ?)?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bt2rsYee98yUOKajPOWnGaibjDJuTpdv0wXJL1NNezybxOqRvAVtLEQQ4aQeMbA4iavvHxw5wMtZUaqrq6ZGQMFg/132, createdBy=37ff2445159, createdName=lxxinhuo, createdTime=Thu Apr 04 00:01:21 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343215, encodeId=e943343215d8, content=嗯嗯，学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Thu Sep 06 06:42:10 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343137, encodeId=a30134313ee6, content=好文章谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 05 23:54:27 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343136, encodeId=328d3431368c, content=好文章谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 05 23:54:22 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2019-04-04 lxxinhuo

    ?(??????????? ?)?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=908082, encodeId=610490808290, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Tue Dec 15 08:56:15 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364084, encodeId=d2f836408479, content=?(??????????? ?)?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bt2rsYee98yUOKajPOWnGaibjDJuTpdv0wXJL1NNezybxOqRvAVtLEQQ4aQeMbA4iavvHxw5wMtZUaqrq6ZGQMFg/132, createdBy=37ff2445159, createdName=lxxinhuo, createdTime=Thu Apr 04 00:01:21 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343215, encodeId=e943343215d8, content=嗯嗯，学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Thu Sep 06 06:42:10 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343137, encodeId=a30134313ee6, content=好文章谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 05 23:54:27 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343136, encodeId=328d3431368c, content=好文章谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 05 23:54:22 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2018-09-06 liumin1987

    嗯嗯，学习了。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=908082, encodeId=610490808290, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Tue Dec 15 08:56:15 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364084, encodeId=d2f836408479, content=?(??????????? ?)?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bt2rsYee98yUOKajPOWnGaibjDJuTpdv0wXJL1NNezybxOqRvAVtLEQQ4aQeMbA4iavvHxw5wMtZUaqrq6ZGQMFg/132, createdBy=37ff2445159, createdName=lxxinhuo, createdTime=Thu Apr 04 00:01:21 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343215, encodeId=e943343215d8, content=嗯嗯，学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Thu Sep 06 06:42:10 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343137, encodeId=a30134313ee6, content=好文章谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 05 23:54:27 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343136, encodeId=328d3431368c, content=好文章谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 05 23:54:22 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2018-09-05 青龙偃月

    好文章谢谢分享！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=908082, encodeId=610490808290, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Tue Dec 15 08:56:15 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364084, encodeId=d2f836408479, content=?(??????????? ?)?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bt2rsYee98yUOKajPOWnGaibjDJuTpdv0wXJL1NNezybxOqRvAVtLEQQ4aQeMbA4iavvHxw5wMtZUaqrq6ZGQMFg/132, createdBy=37ff2445159, createdName=lxxinhuo, createdTime=Thu Apr 04 00:01:21 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343215, encodeId=e943343215d8, content=嗯嗯，学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Thu Sep 06 06:42:10 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343137, encodeId=a30134313ee6, content=好文章谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 05 23:54:27 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343136, encodeId=328d3431368c, content=好文章谢谢分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CD39B82D12E7926.jpg, createdBy=ac2c1946830, createdName=青龙偃月, createdTime=Wed Sep 05 23:54:22 CST 2018, time=2018-09-05, status=1, ipAttribution=)]
    2018-09-05 青龙偃月

    好文章谢谢分享！

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2016 EULAR循证建议：系统性红斑狼疮和／或抗磷脂综合征女性患者计划生育，辅助生殖，妊娠和更年期管理及健康

欧洲抗风湿病联盟(EULAR,The European League Against Rheumatism) · 2016-08-04

中国成人系统性红斑狼疮相关肺动脉高压诊治共识

中国系统性红斑狼疮研究协作组(CSTAR,Chinese SLE Treatment And Research Group) · 2015-02-01

风湿免疫疾病( 系统性红斑狼疮) 超药品说明书用药专家共识

广东省药学会 · 2014-09-25

2014 糖皮质激素在系统性红斑狼疮患者合理应用的专家共识

中国系统性红斑狼疮研究协作组(CSTAR,Chinese SLE Treatment And Research Group) · 2014-06-03

2014 靶向治疗系统性红斑狼疮：国际工作组推荐建议

国外风湿免疫科相关专家小组 · 2014-04-16

2011 中国儿童系统性红斑狼疮诊疗建议

中华医学会儿科学分会免疫学组 · 2011-07-01